How are Pharmakogenetik Medicheck and longevity related?

The MyBody-X Pharmakogenetik Medicheck analyzes genes involved in drug metabolism (e.g., CYP450). Optimizing medication can reduce side effects and improve adherence – factors that may indirectly influence longevity. However, direct evidence linking such a genetic test to extended lifespan is lacking. Personalized dosing may benefit chronic disease management (e.g., hypertension, diabetes), but the evidence for lifespan extension is mostly mechanistic or marketing-driven. Moreover, effect sizes for most PGx markers are small, and lifestyle factors (diet, exercise) have a far greater impact on longevity. The test can serve as a supplementary tool but should not be considered a standalone anti-aging strategy. Caveat: results do not replace professional medical advice.